Clinical Trials Directory

Trials / Completed

CompletedNCT04332952

Damage and Renal Clearance of Glycocalyx in Cardiac Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
Miguel Ayala León · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The glycocalyx is a component of the vascular endothelium that currently plays a relevant role in the modified Starling theory. The manipulation of the heart during cardiac surgery stimulates the release of the natriuretic atrial peptide, which causes endothelial wear in patients undergoing extracorporeal circulation. Dilation of the atrium produces natriuretic atrial peptide, which reduces plasma volume by increasing renal excretion and vascular permeability. The atrial peptide degrades the surface of the coronary endothelium, causing loss of the side cam protein nucleus. This study investigates the relationship between clamping time in cardiac surgery and the clearance of endothelial inflammation markers.

Conditions

Timeline

Start date
2017-08-01
Primary completion
2017-10-01
Completion
2017-12-31
First posted
2020-04-03
Last updated
2020-04-09

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04332952. Inclusion in this directory is not an endorsement.

Damage and Renal Clearance of Glycocalyx in Cardiac Surgery (NCT04332952) · Clinical Trials Directory